LAITH ALTAMIMI: Open Payments
NPI 1457879488 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 31 payments from 20 companies in 2025. Trend: 2023 $934 · 2024 $530 · 2025 $985
Food & beverage: $791Education: $195
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $173 |
| Astellas Pharma US Inc | 2 | $125 |
| SEAGEN INC. | 1 | $95 |
| AstraZeneca Pharmaceuticals LP | 4 | $94 |
| E.R. Squibb & Sons, L.L.C. | 4 | $81 |
| Exelixis Inc. | 3 | $61 |
| SpringWorks Therapeutics, Inc. | 1 | $34 |
| Daiichi Sankyo Inc. | 2 | $31 |
| TerSera Therapeutics LLC | 1 | $31 |
| PFIZER INC. | 1 | $30 |
Products named: CABLIVI, CABOMETYX, TAGRISSO, OGSIVEO, Vanflyta, Zoladex, IBRANCE, Onivyde.
Industry payments across CA — which companies pay providers there.
